Dacarbazine (DTIC) therapy and the Budd-Chiari syndrome
Balda, B.R.; Bassermann, R.
Münchener Medizinische Wochenschrift 122(21): 792-794
1980
ISSN/ISBN: 0341-3098 PMID: 6771598 Document Number: 155625
A case of a 58 years old female is presented, who died because of a Budd-Chiari-syndrome. This complication had developed during treatment with Dacarbazine (DTIC), which was given after surgical removal of a malignant melanoma. The causative relation between the Budd-Chiari-syndrome and this cytostatic drug is discussed, even though the influence of other drugs cannot be excluded.